|
|
 Previous Article | Table of Contents | Next Article 
Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells
Sophie Barillé,
Camélia Akhoundi,
Madeleine Collette,
Marie-Paule Mellerin,
Marie-Josée Rapp,
Jean-Luc Harousseau,
Régis Bataille, and
Martine Amiot
From INSERM U463, Oncogénèse Immunohématologique, Institut de Biologie, Nantes, France; and the Service d'Hématologie, Hôtel-Dieu, Nantes, France.
Multiple myeloma is a very devastating cancer with a high capacity to destroy bone matrix. Matrix metalloproteinases (MMPs) play a critical role in bone remodeling and tumor invasion. In this study, we have investigated the involvement of interstitial collagenase (MMP-1) and gelatinases (MMP-2 and MMP-9) in the biology of multiple myeloma. We show (1) that myeloma cells express MMP-9 and (2) that this expression is not subjected to regulation either by interleukin-6 (IL-6), the major myeloma cell growth factor, or by other cytokines involved in the multiple myeloma cytokine network. In the tumoral environment, we show that bone marrow stromal cells express MMP-1 and MMP-2. Whereas MMP-1 is positively regulated by IL-1 , tumor necrosis factor- , and Oncostatin M, MMP-2 is not modulated by any of these cytokines. To evaluate whether myeloma cells can modify the bone marrow stromal environment, we have examined these MMP activities in coculture. Interestingly, we have observed an upregulation of MMP-1 and a partial conversion of the proMMP-2 into its activated form. We conclude that the increase of MMP activity produced or induced by myeloma cells in these cocultures could favor bone resorption and tumor invasion. Inhibition of such activities could represent a new therapeutical approach in multiple myeloma.
Blood, Vol. 90 No. 4 (August 15), 1997:
pp. 1649-1655
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. Van Themsche, T. Alain, A. E. Kossakowska, S. Urbanski, E. F. Potworowski, and Y. St-Pierre
Stromelysin-2 (Matrix Metalloproteinase 10) Is Inducible in Lymphoma Cells and Accelerates the Growth of Lymphoid Tumors In Vivo
J. Immunol.,
September 15, 2004;
173(6):
3605 - 3611.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Van Valckenborgh, P. I. Croucher, H. De Raeve, C. Carron, E. De Leenheer, S. Blacher, L. Devy, A. Noel, E. De Bruyne, K. Asosingh, et al.
Multifunctional Role of Matrix Metalloproteinases in Multiple Myeloma: A Study in the 5T2MM Mouse Model
Am. J. Pathol.,
September 1, 2004;
165(3):
869 - 878.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H L Neville-Webbe and R E Coleman
The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia
Palliative Medicine,
September 1, 2003;
17(6):
539 - 553.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Tarte, F. Zhan, J. De Vos, B. Klein, and J. Shaughnessy Jr
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation
Blood,
July 15, 2003;
102(2):
592 - 600.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Giuliani, S. Colla, R. Sala, M. Moroni, M. Lazzaretti, S. La Monica, S. Bonomini, M. Hojden, G. Sammarelli, S. Barille, et al.
Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease
Blood,
December 15, 2002;
100(13):
4615 - 4621.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Fernandez, S. Amoroso, S. Sharpe, G. M. Jones, V. Bliskovski, A. Kovalchuk, L. M. Wakefield, S.-J. Kim, M. Potter, and J. J. Letterio
Disruption of Transforming Growth Factor {beta} Signaling by a Novel Ligand-dependent Mechanism
J. Exp. Med.,
May 20, 2002;
195(10):
1247 - 1255.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. C. Anderson, J. D. Shaughnessy Jr., B. Barlogie, J.-L. Harousseau, and G. D. Roodman
Multiple Myeloma
Hematology,
January 1, 2002;
2002(1):
214 - 240.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
G. D. Roodman
Biology of Osteoclast Activation in Cancer
J. Clin. Oncol.,
August 1, 2001;
19(15):
3562 - 3571.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Nishibe, G. Parry, A. Ishida, S. Aziz, J. Murray, Y. Patel, S. Rahman, K. Strand, K. Saito, Y. Saito, et al.
Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation
Blood,
February 1, 2001;
97(3):
692 - 699.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Raje and K. C. Anderson
Introduction: the evolving role of bisphosphonate therapy in multiple myeloma
Blood,
July 15, 2000;
96(2):
381 - 383.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Barille, R. Bataille, M.-J. Rapp, J.-L. Harousseau, and M. Amiot
Production of Metalloproteinase-7 (Matrilysin) by Human Myeloma Cells and Its Potential Involvement in Metalloproteinase-2 Activation
J. Immunol.,
November 15, 1999;
163(10):
5723 - 5728.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Qin, Y. Sun, and E. N. Benveniste
The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells
J. Biol. Chem.,
October 8, 1999;
274(41):
29130 - 29137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Thabard, S. Barille, M. Collette, J.-L. Harousseau, M.-J. Rapp, R. Bataille, and M. Amiot
Myeloma Cells Release Soluble Interleukin-6R{{alpha}} in Relation to Disease Progression by Two Distinct Mechanisms: Alternative Splicing and Proteolytic Cleavage
Clin. Cancer Res.,
October 1, 1999;
5(10):
2693 - 2697.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Kossakowska, D. R. Edwards, C. Prusinkiewicz, M. C. Zhang, D. Guo, S. J. Urbanski, T. Grogan, L. A. Marquez, and A. Janowska-Wieczorek
Interleukin-6 Regulation of Matrix Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metalloproteinase (TIMP-1) Expression in Malignant Non-Hodgkin's Lymphomas
Blood,
September 15, 1999;
94(6):
2080 - 2089.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Ries, F. Loher, C. Zang, M. G. Ismair, and P. E. Petrides
Matrix Metalloproteinase Production by Bone Marrow Mononuclear Cells from Normal Individuals and Patients with Acute and Chronic Myeloid Leukemia or Myelodysplastic Syndromes
Clin. Cancer Res.,
May 1, 1999;
5(5):
1115 - 1124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Vacca, D. Ribatti, M. Presta, M. Minischetti, M. Iurlaro, R. Ria, A. Albini, F. Bussolino, and F. Dammacco
Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma
Blood,
May 1, 1999;
93(9):
3064 - 3073.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Qin, J. D. Moellinger, A. Wells, L. J. Windsor, Y. Sun, and E. N. Benveniste
Transcriptional Suppression of Matrix Metalloproteinase-2 Gene Expression in Human Astroglioma Cells by TNF-{alpha} and IFN-{gamma}
J. Immunol.,
December 15, 1998;
161(12):
6664 - 6673.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
